Confidence interval estimation for the win probability in cluster randomized trials with hierarchical composite endpoints using win fractions.

IF 2.4 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Clinical Trials Pub Date : 2026-06-01 Epub Date: 2026-02-23 DOI:10.1177/17407745261417308
Emma Davies Smith, Yun-Hee Choi, Vipul Jairath, Guangyong Zou
{"title":"Confidence interval estimation for the win probability in cluster randomized trials with hierarchical composite endpoints using win fractions.","authors":"Emma Davies Smith, Yun-Hee Choi, Vipul Jairath, Guangyong Zou","doi":"10.1177/17407745261417308","DOIUrl":null,"url":null,"abstract":"<p><p>Background/AimsCluster randomized trials with multiple endpoints feature complex correlation structures. Estimating treatment effects in a meaningful way that respects differences in scale and clinical importance is challenging. Pairwise comparison methods address these challenges by constructing all pairs featuring one treatment and one control participant, then evaluating endpoints in hierarchical order. For cluster randomized trials featuring such a \"hierarchical composite endpoint,\" we develop large-sample confidence interval estimators and hypothesis tests for the nonparametric treatment effect referred to here as the \"win probability.\"MethodsFor each pair of participants (one treated and one control), responses on each endpoint are compared in order of descending clinical importance until it can be determined which participant responded better (\"won\") or all endpoints are exhausted. Dividing the number of wins attributed to the treatment arm by the total number of \"pairwise comparisons\" yields a point estimate of the win probability. The win probability can be transformed into alternative effect measures, including the \"win difference\" and \"win odds.\" A two-stage procedure, or \"win fraction\" approach, is used to obtain variance estimators for the win probability. Each participant's multivariate response is transformed into a univariate \"win fraction,\" which quantifies the proportion of times they won when compared to all participants in the comparison arm. A working linear mixed model is applied to the win fractions to obtain cluster-adjusted point estimates of the win probability and its variance. Inference proceeds by the central limit theorem. Simulation is used to assess the performance of the proposed estimators for a hierarchical composite endpoint comprised of one binary component (more important) and one continuous component (less important) across a range of cluster trial designs. Performance of an empirical bootstrap estimator is also investigated. A case study using data from the REACT cluster trial demonstrates application of the methods, and corresponding SAS and R code is provided.ResultsSimulation suggests that the nominal 95% coverage probability is well maintained and type I error is controlled. Due to the large-sample nature of our method, confidence intervals may be conservative (over coverage) for fewer than 30 clusters. In comparison, the empirical bootstrap estimator is liberal (under coverage) for all numbers of randomized clusters (up to 50).ConclusionOur win fraction method uses a working linear mixed model to obtain confidence intervals and hypothesis tests which respect coverage and type I error. It is faster than the bootstrap, applicable to multiple components on different scales, bypasses specification of complex correlation matrices, permits adjustment, and can be implemented in existing software.</p>","PeriodicalId":10685,"journal":{"name":"Clinical Trials","volume":" ","pages":"347-357"},"PeriodicalIF":2.4000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12931659/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Trials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17407745261417308","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/23 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background/AimsCluster randomized trials with multiple endpoints feature complex correlation structures. Estimating treatment effects in a meaningful way that respects differences in scale and clinical importance is challenging. Pairwise comparison methods address these challenges by constructing all pairs featuring one treatment and one control participant, then evaluating endpoints in hierarchical order. For cluster randomized trials featuring such a "hierarchical composite endpoint," we develop large-sample confidence interval estimators and hypothesis tests for the nonparametric treatment effect referred to here as the "win probability."MethodsFor each pair of participants (one treated and one control), responses on each endpoint are compared in order of descending clinical importance until it can be determined which participant responded better ("won") or all endpoints are exhausted. Dividing the number of wins attributed to the treatment arm by the total number of "pairwise comparisons" yields a point estimate of the win probability. The win probability can be transformed into alternative effect measures, including the "win difference" and "win odds." A two-stage procedure, or "win fraction" approach, is used to obtain variance estimators for the win probability. Each participant's multivariate response is transformed into a univariate "win fraction," which quantifies the proportion of times they won when compared to all participants in the comparison arm. A working linear mixed model is applied to the win fractions to obtain cluster-adjusted point estimates of the win probability and its variance. Inference proceeds by the central limit theorem. Simulation is used to assess the performance of the proposed estimators for a hierarchical composite endpoint comprised of one binary component (more important) and one continuous component (less important) across a range of cluster trial designs. Performance of an empirical bootstrap estimator is also investigated. A case study using data from the REACT cluster trial demonstrates application of the methods, and corresponding SAS and R code is provided.ResultsSimulation suggests that the nominal 95% coverage probability is well maintained and type I error is controlled. Due to the large-sample nature of our method, confidence intervals may be conservative (over coverage) for fewer than 30 clusters. In comparison, the empirical bootstrap estimator is liberal (under coverage) for all numbers of randomized clusters (up to 50).ConclusionOur win fraction method uses a working linear mixed model to obtain confidence intervals and hypothesis tests which respect coverage and type I error. It is faster than the bootstrap, applicable to multiple components on different scales, bypasses specification of complex correlation matrices, permits adjustment, and can be implemented in existing software.

用胜利分数估计具有分层复合终点的聚类随机试验中获胜概率的置信区间。
背景/目的多终点的集群随机试验具有复杂的相关结构。以一种有意义的方式评估治疗效果,尊重规模和临床重要性的差异是具有挑战性的。两两比较方法通过构建具有一个处理和一个对照参与者的所有配对,然后按层次顺序评估终点来解决这些挑战。对于具有这种“分层复合终点”的集群随机试验,我们开发了大样本置信区间估计器和假设检验,用于此处称为“获胜概率”的非参数治疗效果。方法对于每一对参与者(一个治疗组和一个对照组),按照临床重要性降序比较每个终点的反应,直到可以确定哪个参与者反应更好(“赢”)或所有终点都耗尽。将治疗组的获胜次数除以“两两比较”的总次数,得出获胜概率的点估计。获胜概率可以转化为可选效果度量,包括“获胜差”和“获胜赔率”。一个两阶段的程序,或“胜利分数”的方法,是用来获得方差估计的胜利概率。每个参与者的多变量反应被转化为单变量“获胜分数”,该分数量化了他们与比较组中所有参与者相比获胜的次数比例。将一个有效的线性混合模型应用于获胜分数,以获得获胜概率及其方差的聚类调整点估计。推论由中心极限定理进行。模拟用于评估所提出的估计器在一系列聚类试验设计中对由一个二元成分(更重要)和一个连续成分(不太重要)组成的分层复合端点的性能。研究了经验自举估计器的性能。使用REACT集群试验数据的案例研究演示了方法的应用,并提供了相应的SAS和R代码。结果仿真结果表明,该方法能很好地维持95%的标称覆盖率,ⅰ类误差得到控制。由于我们方法的大样本性质,对于少于30个集群,置信区间可能是保守的(超过覆盖范围)。相比之下,经验自举估计器对于所有数量的随机集群(最多50个)都是自由的(在覆盖范围内)。结论该方法采用工作线性混合模型,得到了考虑覆盖率和I型误差的置信区间和假设检验。它比bootstrap更快,适用于不同尺度的多个组件,绕过复杂相关矩阵的规范,允许调整,并且可以在现有软件中实现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Trials
Clinical Trials 医学-医学:研究与实验
CiteScore
4.10
自引率
3.70%
发文量
82
审稿时长
6-12 weeks
期刊介绍: Clinical Trials is dedicated to advancing knowledge on the design and conduct of clinical trials related research methodologies. Covering the design, conduct, analysis, synthesis and evaluation of key methodologies, the journal remains on the cusp of the latest topics, including ethics, regulation and policy impact.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书